Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

Overview of attention for article published in Molecular Imaging and Biology, July 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Readers on

mendeley: 44 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,645 followers.

RT @rudiwerner2017: Precision medicine for pancreatic NET patients - Radiomics predict outcome to PRRT! Available open access: https://t.co…

17 Sep 2018

Reply Repost Favourite

RT @rudiwerner2017: Precision medicine for pancreatic NET patients - Radiomics predict outcome to PRRT! Available open access: https://t.co…

23 Aug 2018

Reply Repost Favourite

Precision medicine for pancreatic NET patients - Radiomics predict outcome to PRRT! Available open access: https://t.co/thpI3RG3Wg This project receives funding from the @EU_H2020 Research & Innovation Programme. @MSCActions @EU_H2020

14 Aug 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.